Middle East And Africa Artificial Blood Substitutes Market Analysis

Request for TOC Request for TOC Speak to Analyst Speak to Analyst Buy Now Buy Now Inquire Before Buying Inquire Before Free Sample Report Free Sample Report

Middle East And Africa Artificial Blood Substitutes Market Analysis

  • Healthcare
  • Published Report
  • Aug 2021
  • MEA
  • 350 Pages
  • No of Tables: 36
  • No of Figures: 24

Table of Content

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF MIDDLE EAST AND AFRICA ARTIFICIAL BLOOD SUBSTITUTES MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.7 MULTIVARIATE MODELLING

2.8 PRODUCT TYPE LIFELINE CURVE

2.9 DBMR MARKET POSITION GRID

2.1 MARKET APPLICATION COVERAGE GRID

2.11 VENDOR SHARE ANALYSIS

2.12 SECONDARY SOURCES

2.13 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

5 PATENT ANALYSIS OF MIDDLE EAST AND AFRICA ARTIFICIAL BLOOD SUBSTITUTES MARKET

5.1 DBMR ANALYSIS

5.2 COUNTRY-LEVEL ANALYSIS

5.3 YEARWISE ANALYSIS

6 MIDDLE EAST AND AFRICA ARTIFICIAL BLOOD SUBSTITUTES MARKET: PIPELINE ANALYSIS

7 MARKET OVERVIEW

7.1 DRIVERS

7.1.1 INCREASE IN DEMAND FOR BLOOD TRANSFUSION

7.1.2 INCREASED FUNDING FOR PRODUCT DEVELOPMENT

7.1.3 RISE IN BLOOD-RELATED DISORDERS AND TRAUMA CASES

7.1.4 LIMITED AVAILABILITY OF FRESH BLOOD AND SMALL STORAGE PERIODS OF FRESH BLOOD

7.2 RESTRAINTS

7.2.1 STRINGENT REGULATORY APPROVAL PROCESS

7.2.2 HIGH-COST PRODUCTION OF ARTIFICIAL BLOOD SUBSTITUTE

7.2.3 UNAWARENESS ABOUT THE ARTIFICIAL BLOOD SUBSTITUTES

7.3 OPPORTUNITIES

7.3.1 INCREASE IN AWARENESS REGARDING THE ADVANTAGES OF ARTIFICIAL BLOOD OVER HUMAN BLOOD

7.3.2 RISE IN DEMAND FOR BLOOD SUBSTITUTES AND INSUFFICIENT NUMBER OF BLOOD DONORS

7.3.3 RISE IN NUMBER OF RESEARCH & DEVELOPMENTS ON ARTIFICIAL BLOOD

7.3.4 AMPLE AMOUNT OF SOURCES FOR PRODUCTION OF ARTIFICIAL BLOOD SUBSTITUTE

7.4 CHALLENGES

7.4.1 INSTABILITY OF ARTIFICIAL BLOOD PRODUCT

7.4.2 EXTENDED CLINICAL TRAILS

7.4.3 SIDE EFFECTS OF ARTIFICIAL BLOOD SUBSTITUTES

8 IMPACT OF COVID-19 ON THE MIDDLE EAST AND AFRICA ARTIFICIAL BLOOD SUBSTITUTES MARKET

8.1 AFTERMATH OF COVID-19

8.2 IMPACT ON SUPPLY AND DEMAND

8.3 THE INCREASING DEMAND FOR BLOOD TRANSFUSION IS LEADING THE ARTIFICIAL BLOOD SUBSTITUTES MARKET.

8.4 CONCLUSION

9 MIDDLE EAST AND AFRICA ARTIFICIAL BLOOD SUBSTITUTES MARKET, BY PRODUCT TYPE

9.1 OVERVIEW

9.2 HEMOGLOBIN-BASED OXYGEN CARRIES (HBOCS)

9.2.1 OXYGLOBIN

9.2.2 HEMOPURE

9.3 PERFLUOROCARBON (PFCS)

9.3.1 PERFTORAN

9.3.2 OTHERS

10 MIDDLE EAST AND AFRICA ARTIFICIAL BLOOD SUBSTITUTES MARKET, BY SOURCE

10.1 OVERVIEW

10.2 ANIMAL BLOOD

10.3 HUMAN BLOOD

10.4 MICROORGANISM BASED RECOMBINANT HB

10.5 STEM CELLS

10.6 SYNTHETIC POLYMERS

11 MIDDLE EAST AND AFRICA ARTIFICIAL BLOOD SUBSTITUTES MARKET, BY APPLICATION

11.1 OVERVIEW

11.2 INJURIES

11.3 CARDIOVASCULAR DISEASES

11.4 ORGAN TRANSPLANT

11.5 MATERNAL CONDITION

11.6 MALIGNANT NEOPLASMA

11.7 NEONATAL CONDITIONS

12 MIDDLE EAST AND AFRICA ARTIFICIAL BLOOD SUBSTITUTES MARKET, BY END USER

12.1 OVERVIEW

12.2 HOSPITAL AND CLINICS

12.3 BLOOD BANKS

12.4 OTHERS

13 MIDDLE EAST AND AFRICA ARTIFICIAL BLOOD SUBSTITUTES MARKET, BY REGION

13.1 MIDDLE EAST & AFRICA

13.1.1 SOUTH AFRICA

13.1.2 REST OF MIDDLE EAST & AFRICA

14 MIDDLE EAST AND AFRICA ARTIFICIAL BLOOD SUBSTITUTES MARKET: COMPANY LANDSCAPE

14.1 COMPANY SHARE ANALYSIS: MIDDLE EAST AND AFRICA

14.2 MIDDLE EAST AND AFRICA ARTIFICIAL BLOOD SUBSTITUTES MARKET: COMPANY SHARE 2020 (%)

15 SWOT

16 COMPANY PROFILE

16.1 KALOCYTE, INC.

16.1.1 COMPANY SNAPSHOT

16.1.2 COMPANY SAHRE ANALYSIS

16.1.3 PRODUCT PORTFOLIO

16.1.4 RECENT DEVELOPMENTS

16.2 HEMARINA

16.2.1 COMPANY SNAPSHOT

16.2.2 COMPANY SHARE ANALYSIS

16.2.3 PRODUCT PORTFOLIO

16.2.4 RECENT DEVELOPMENTS

16.3 HEMOGLOBIN OXYGEN THERAPEUTICS LLC

16.3.1 COMPANY SNAPSHOT

16.3.2 COMPANY SHARE ANALYSIS

16.3.3 PRODUCT PORTFOLIO

16.3.4 RECENT DEVELOPMENTS

16.4 LLC “VISUSMED”

16.4.1 COMPANY SNAPSHOT

16.4.2 COMPANY SHARE ANALYSIS

16.4.3 PRODUCT PORTFOLIO

16.4.4 RECENT DEVELOPMENT

16.5 EUROPEAN MEDICINES AGENCY

16.5.1 COMPANY SNAPSHOT

16.5.2 REVENUE ANALYSIS

16.5.3 COMPANY SHARE ANALYSIS

16.5.4 PRODUCT PORTFOLIO

16.5.5 RECENT DEVELOPMENT

16.6 AURUM BIOSCIENCES

16.6.1 COMPANY SNAPSHOT

16.6.2 PRODUCT PORTFOLIO

16.6.3 RECENT DEVELOPMENTS

16.7 BOSTON THERAPEUTICS, INC.

16.7.1 COMPANY SNAPSHOT

16.7.2 REVENUE ANALYSIS

16.7.3 PRODUCT PORTFOLIO

16.7.4 RECENT DEVELOPMENT

16.8 NANOBLOOD LLC

16.8.1 COMPANY SNAPSHOT

16.8.2 PRODUCT PORTFOLIO

16.8.3 RECENT DEVELOPMENT

16.9 NUVOX PHARMA

16.9.1 COMPANY SNAPSHOT

16.9.2 PRODUCT PORTFOLIO

16.9.3 RECENT DEVELOPMENTS

16.1 OPK BIOTECH LLC

16.10.1 COMPANY SNAPSHOT

16.10.2 PRODUCT PORTFOLIO

16.10.3 RECENT DEVELOPMENT

16.11 OXYVITA INC

16.11.1 COMPANY SNAPSHOT

16.11.2 PRODUCT PORTFOLIO

16.11.3 RECENT DEVELOPMENT

16.12 PROLONG PHARMACEUTICALS, LLC

16.12.1 COMPANY SNAPSHOT

16.12.2 PRODUCT PORTFOLIO

16.12.3 RECENT DEVELOPMENT

17 QUESTIONNAIRE

18 RELATED REPORTS

List of Table

LIST OF TABLES 

TABLE 1 MIDDLE EAST AND AFRICA ARTIFICIAL BLOOD SUBSTITUTES MARKET, PRODUCT TYPE, 2019-2028 (USD THOUSAND)

TABLE 2 MIDDLE EAST AND AFRICA HEMOGLOBIN-BASED OXYGEN CARRIES (HBOCS) IN ARTIFICIAL BLOOD SUBSTITUTES MARKET, BY REGION, 2019-2028 (USD THOUSAND)

TABLE 3 MIDDLE EAST AND AFRICA HEMOGLOBIN-BASED OXYGEN CARRIERS (HBOCS) IN ARTIFICIAL BLOOD SUBSTITUTES MARKET, BY PRODUCT TYPE, 2019-2028 (USD THOUSAND)

TABLE 4 MIDDLE EAST AND AFRICA PERFLUOROCARBON (PFCS) IN ARTIFICIAL BLOOD SUBSTITUTES MARKET, BY REGION, 2019-2028 (USD THOUSAND)

TABLE 5 MIDDLE EAST AND AFRICA PERFLUOROCARBON (PFCS) IN ARTIFICIAL BLOOD SUBSTITUTES MARKET, BY PRODUCT TYPE, 2019-2028 (USD THOUSAND)

TABLE 6 MIDDLE EAST AND AFRICA ARTIFICIAL BLOOD SUBSTITUTES MARKET, BY SOURCE, 2019-2028 (USD THOUSAND)

TABLE 7 MIDDLE EAST AND AFRICA ANIMAL BLOOD IN ARTIFICIAL BLOOD SUBSTITUTES MARKET, BY REGION, 2019-2028 (USD THOUSAND)

TABLE 8 MIDDLE EAST AND AFRICA HUMAN BLOOD IN ARTIFICIAL BLOOD SUBSTITUTES MARKET, BY REGION, 2019-2028 (USD THOUSAND)

TABLE 9 MIDDLE EAST AND AFRICA MICROORGANISM BASED RECOMBINANT HB IN ARTIFICIAL BLOOD SUBSTITUTES MARKET, BY REGION, 2019-2028 (USD THOUSAND)

TABLE 10 MIDDLE EAST AND AFRICA STEM CELLS IN ARTIFICIAL BLOOD SUBSTITUTES MARKET, BY REGION, 2019-2028 (USD THOUSAND)

TABLE 11 MIDDLE EAST AND AFRICA SYNTHETIC POLYMERS IN ARTIFICIAL BLOOD SUBSTITUTES MARKET, BY REGION, 2019-2028 (USD THOUSAND)

TABLE 12 MIDDLE EAST AND AFRICA ARTIFICIAL BLOOD SUBSTITUTES MARKET, BY APPLICATION, 2019-2028 (USD THOUSAND)

TABLE 13 MIDDLE EAST AND AFRICA INJURIES IN ARTIFICIAL BLOOD SUBSTITUTES MARKET, BY REGION, 2019-2028 (USD THOUSAND)

TABLE 14 MIDDLE EAST AND AFRICA CARDIOVASCULAR DISEASES IN ARTIFICIAL BLOOD SUBSTITUTES MARKET, BY REGION, 2019-2028 (USD THOUSAND)

TABLE 15 MIDDLE EAST AND AFRICA ORGAN TRANSPLANT IN ARTIFICIAL BLOOD SUBSTITUTES MARKET, BY REGION, 2019-2028 (USD THOUSAND)

TABLE 16 MIDDLE EAST AND AFRICA MATERNAL CONDITION IN ARTIFICIAL BLOOD SUBSTITUTES MARKET, BY REGION, 2019-2028 (USD THOUSAND)

TABLE 17 MIDDLE EAST AND AFRICA MALIGNANT NEOPLASMA IN ARTIFICIAL BLOOD SUBSTITUTES MARKET, BY REGION, 2019-2028 (USD THOUSAND)

TABLE 18 MIDDLE EAST AND AFRICA NEONATAL CONDITIONS IN ARTIFICIAL BLOOD SUBSTITUTES MARKET, BY REGION, 2019-2028 (USD THOUSAND)

TABLE 19 MIDDLE EAST AND AFRICA ARTIFICIAL BLOOD SUBSTITUTES MARKET, BY END USER, 2019-2028 (USD THOUSAND)

TABLE 20 MIDDLE EAST AND AFRICA HOSPITALS AND CLINICS IN ARTIFICIAL BLOOD SUBSTITUTES MARKET, BY REGION, 2019-2028 (USD THOUSAND)

TABLE 21 MIDDLE EAST AND AFRICA BLOOD BANKS IN ARTIFICIAL BLOOD SUBSTITUTES MARKET, BY REGION, 2019-2028 (USD THOUSAND)

TABLE 22 MIDDLE EAST AND AFRICA OTHERS IN ARTIFICIAL BLOOD SUBSTITUTES MARKET, BY REGION, 2019-2028 (USD THOUSAND)

TABLE 23 MIDDLE EAST & AFRICA ARTIFICIAL BLOOD SUBSTITUTES MARKET, BY COUNTRY, 2019-2028 (USD THOUSAND)

TABLE 24 MIDDLE EAST & AFRICA ARTIFICIAL BLOOD SUBSTITUTES MARKET, BY PRODUCT TYPE, 2019-2028 (USD THOUSAND)

TABLE 25 MIDDLE EAST & AFRICA HEMOGLOBIN-BASED OXYGEN CARRIERS (HBOCS) IN ARTIFICIAL BLOOD SUBSTITUTES MARKET, BY PRODUCT TYPE, 2019-2028 (USD THOUSAND)

TABLE 26 MIDDLE EAST & AFRICA PERFLUOROCARBON (PFCS) IN ARTIFICIAL BLOOD SUBSTITUTES MARKET, BY PRODUCT TYPE, 2019-2028 (USD THOUSAND)

TABLE 27 MIDDLE EAST & AFRICA ARTIFICIAL BLOOD SUBSTITUTES MARKET, BY SOURCE, 2019-2028 (USD THOUSAND)

TABLE 28 MIDDLE EAST & AFRICA ARTIFICIAL BLOOD SUBSTITUTES MARKET, BY APPLICATION, 2019-2028 (USD THOUSAND)

TABLE 29 MIDDLE EAST & AFRICA ARTIFICIAL BLOOD SUBSTITUTES MARKET, BY END USER, 2019-2028 (USD THOUSAND)

TABLE 30 SOUTH AFRICA ARTIFICIAL BLOOD SUBSTITUTES MARKET, BY PRODUCT TYPE, 2019-2028 (USD THOUSAND)

TABLE 31 SOUTH AFRICA HEMOGLOBIN-BASED OXYGEN CARRIERS (HBOCS) IN ARTIFICIAL BLOOD SUBSTITUTES MARKET, BY PRODUCT TYPE, 2019-2028 (USD THOUSAND)

TABLE 32 SOUTH AFRICA PERFLUOROCARBON (PFCS) IN ARTIFICIAL BLOOD SUBSTITUTES MARKET, BY PRODUCT TYPE, 2019-2028 (USD THOUSAND)

TABLE 33 SOUTH AFRICA ARTIFICIAL BLOOD SUBSTITUTES MARKET, BY SOURCE, 2019-2028 (USD THOUSAND)

TABLE 34 SOUTH AFRICA ARTIFICIAL BLOOD SUBSTITUTES MARKET, BY APPLICATION, 2019-2028 (USD THOUSAND)

TABLE 35 SOUTH AFRICA ARTIFICIAL BLOOD SUBSTITUTES MARKET, BY END USER, 2019-2028 (USD THOUSAND)

TABLE 36 REST OF MIDDLE EAST & AFRICA ARTIFICIAL BLOOD SUBSTITUTES MARKET, BY PRODUCT TYPE, 2019-2028 (USD THOUSAND)

 

List of Figure

LIST OF FIGURES 

FIGURE 1 MIDDLE EAST AND AFRICA ARTIFICIAL BLOOD SUBSTITUTES MARKET: SEGMENTATION

FIGURE 2 MIDDLE EAST AND AFRICA ARTIFICIAL BLOOD SUBSTITUTES MARKET: DATA TRIANGULATION

FIGURE 3 MIDDLE EAST AND AFRICA ARTIFICIAL BLOOD SUBSTITUTES MARKET: DROC ANALYSIS

FIGURE 4 MIDDLE EAST AND AFRICA ARTIFICIAL BLOOD SUBSTITUTES MARKET: MIDDLE EAST AND AFRICA VS REGIONAL MARKET ANALYSIS

FIGURE 5 MIDDLE EAST AND AFRICA ARTIFICIAL BLOOD SUBSTITUTES MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 MIDDLE EAST AND AFRICA ARTIFICIAL BLOOD SUBSTITUTES MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 MIDDLE EAST AND AFRICA ARTIFICIAL BLOOD SUBSTITUTES MARKET: DBMR MARKET POSITION GRID

FIGURE 8 MIDDLE EAST AND AFRICA ARTIFICIAL BLOOD SUBSTITUTES MARKET: MARKET APPLICATION COVERAGE GRID

FIGURE 9 MIDDLE EAST AND AFRICA ARTIFICIAL BLOOD SUBSTITUTES MARKET: DBMR VENDOR SHARE ANALYSIS

FIGURE 10 MIDDLE EAST AND AFRICA ARTIFICIAL BLOOD SUBSTITUTES MARKET: SEGMENTATION

FIGURE 11 INCREASED DEMAND FOR BLOOD TRANSFUSION IS EXPECTED TO DRIVE THE MIDDLE EAST AND AFRICA ARTIFICIAL BLOOD SUBSTITUTES MARKET IN THE FORECAST PERIOD OF 2021 TO 2028

FIGURE 12 HAEMOGLOBIN-BASED OXYGEN CARRIERS (HBOCS) SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST AND AFRICA ARTIFICIAL BLOOD SUBSTITUTES MARKET IN 2021 & 2028

FIGURE 13 PATENT REGISTERED FOR ARTIFICIAL BLOOD SUBSTITUTES, BY COUNTRY

FIGURE 14 PATENT REGISTERED YEAR (2017 - 2021)

FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF MIDDLE EAST AND AFRICA ARTIFICIAL BLOOD SUBSTITUTES MARKET

FIGURE 16 MIDDLE EAST AND AFRICA ARTIFICIAL BLOOD SUBSTITUTES MARKET, BY PRODUCT TYPE, 2020

FIGURE 17 MIDDLE EAST AND AFRICA ARTIFICIAL BLOOD SUBSTITUTES MARKET, BY SOURCE, 2020

FIGURE 18 MIDDLE EAST AND AFRICA ARTIFICIAL BLOOD SUBSTITUTES MARKET, BY APPLICATION, 2020

FIGURE 19 MIDDLE EAST AND AFRICA ARTIFICIAL BLOOD SUBSTITUTES MARKET, BY END USER, 2020

FIGURE 20 MIDDLE EAST & AFRICA ARTIFICIAL BLOOD SUBSTITUTES MARKET: SNAPSHOT (2020)

FIGURE 21 MIDDLE EAST & AFRICA ARTIFICIAL BLOOD SUBSTITUTES MARKET: BY COUNTRY (2020)

FIGURE 22 MIDDLE EAST & AFRICA ARTIFICIAL BLOOD SUBSTITUTES MARKET: BY COUNTRY (2021 & 2028)

FIGURE 23 MIDDLE EAST & AFRICA ARTIFICIAL BLOOD SUBSTITUTES MARKET: BY COUNTRY (2020 & 2028)

FIGURE 24 MIDDLE EAST & AFRICA ARTIFICIAL BLOOD SUBSTITUTES MARKET: BY PRODUCT TYPE (2021 & 2028)